Q2 2017 Holdings
Filed 2017-08-02 | 8 holdings | $127.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Audentes Therapeutics, Inc.(BOLDEUR) | Common Stock | 05070R104 | $34.6M | 1,806,832 | 27.2% |
| Achaogen, Inc. | Common Stock | 004449104 | $27.9M | 1,281,152 | 21.9% |
| ImmuneDesign Corp. | Common Stock | 45252L103 | $21.3M | 2,208,210 | 16.8% |
| Ocular Therapeutix, Inc.(OCUL) | Common Stock | 67576A100 | $20.5M | 2,215,384 | 16.2% |
| Clovis Oncology, Inc.(CLVSEUR) | Common Stock | 189464100 | $9.5M | 101,855 | 7.5% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common Stock | 23257D103 | $6.0M | 1,048,601 | 4.8% |
| Second Sight Medical Products, Inc. | Common Stock | 81362J100 | $5.6M | 4,492,975 | 4.4% |
| OpGen, Inc. | Common Stock | 68373L109 | $1.6M | 2,554,211 | 1.3% |